Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reduced von Willebrand factor survival in von Willebrand disease: pathophysiologic and clinical relevance.

Journal of thrombosis and haemostasis : JTH - 1 Jul 2009

Castaman G, Tosetto A, Rodeghiero F

Abstract excerpt

Von Willebrand disease (VWD) is characterized by a wide heterogeneity of clinical and laboratory phenotypes. The complexity of the phenotype is further increased by a highly variable removal rate of von Willebrand factor (VWF) released by desmopressin, which is independent of post-infusion peak l...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ABO Blood-Group System
Share to Deamino Arginine Vasopressin
Share to ABO gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to VWF gene

Share to Mutation

Share to von Willebrand Diseases

Share to von Willebrand Factor

Source

Identifiers

PMID: 19630772
DOI: 10.1111/j.1538-7836.2009.03381.x

Genes

VWF
ABO

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19630772-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reduced von Willebrand factor survival in von Willebrand disease: pathophysiologic and clinical relevance.PMID 19630772Read ↗

Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series.Semantic proximity Read ↗

Clearance of von Willebrand factorSemantic proximity Read ↗

Reduced von Willebrand factor survival in type Vicenza von Willebrand disease.Semantic proximity Read ↗

Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease.Semantic proximity Read ↗

An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation.Semantic proximity Read ↗

Current treatment of von Willebrand's disease.Semantic proximity Read ↗

von Willebrand factor clearance – biological mechanisms and clinical significanceSemantic proximity Read ↗

Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutations.Semantic proximity Read ↗

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia.Semantic proximity Read ↗

Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.Semantic proximity Read ↗

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).Semantic proximity Read ↗

[Perioperative therapy of von Willebrand disease. Demonstration of pathophysiology, clinical problems and therapy options using two case reports].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.